Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OMER · against 1,336 other Healthcare companies
Ranked #382 of 1,337 · scores higher than 71% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 70–79, including OMER · Click a bar to see the companies
Mainly thanks to its earnings yield, which is stronger than most Healthcare peers.
| Metric | OMER | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 9.0% | 1.5% | 93% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | -4.8% | 4.2% | 22% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -5.2% | -1.0% | 37% | 20% | |
| Book yieldHigher is better · 1,306 reported | -3.9% | 37.9% | 4% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 382 | 975.0B INR (≈$11.7B) | 71 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 65 |
| 382 | 2.4B SGD (≈$1.8B) | 71 | 79 |
| 382 | 3.1B BRL (≈$560M) | 71 | 39 |
| 382 | 14.9B EUR (≈$16.4B) | 71 | 52 |
| 382 | 1.3B USD | 71 | 29 |
| 382 | 10.9B EUR (≈$11.9B) | 71 | 59 |
| 396 | 5.8B CNY (≈$807M) | 70 | 67 |
| 396 | 1.8B HKD (≈$224M) | 70 | 59 |
| 396 | 11.6B USD | 70 | 56 |